190 related articles for article (PubMed ID: 30797241)
41. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
42. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
43. Computed tomographic demonstration of internal mammary lymph-node metastasis in patients with locally recurrent breast carcinoma.
Meyer JE; Munzenrider JE
Radiology; 1981 Jun; 139(3):661-3. PubMed ID: 7232733
[TBL] [Abstract][Full Text] [Related]
44. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.
Yates L; Kirby A; Crichton S; Gillett C; Cane P; Fentiman I; Sawyer E
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2093-103. PubMed ID: 21530101
[TBL] [Abstract][Full Text] [Related]
46. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
[TBL] [Abstract][Full Text] [Related]
47. The prognostic significance of early stage lymph node positivity in operable invasive breast carcinoma: number or stage.
Rakha EA; Morgan D; Macmillan D
J Clin Pathol; 2012 Jul; 65(7):624-30. PubMed ID: 22523340
[TBL] [Abstract][Full Text] [Related]
48. Detection of internal mammary lymph node enlargement: comparison of CT scans and conventional roentgenograms.
Scott WW; Fishman EK
Clin Imaging; 1991; 15(4):268-72. PubMed ID: 1742676
[TBL] [Abstract][Full Text] [Related]
49. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
50. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
51. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Wahl RL; Siegel BA; Coleman RE; Gatsonis CG;
J Clin Oncol; 2004 Jan; 22(2):277-85. PubMed ID: 14722036
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
Orsaria P; Chiaravalloti A; Caredda E; Marchese PV; Titka B; Anemona L; Portarena I; Schillaci O; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Dec; 38(12):6639-6652. PubMed ID: 30504372
[TBL] [Abstract][Full Text] [Related]
53. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
Soni NK; Spillane AJ
ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
[TBL] [Abstract][Full Text] [Related]
54. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Koolen BB; van der Leij F; Vogel WV; Rutgers EJ; Vrancken Peeters MJ; Elkhuizen PH; Valdés Olmos RA
Acta Oncol; 2014 Jan; 53(1):50-7. PubMed ID: 23672678
[TBL] [Abstract][Full Text] [Related]
55. The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patients.
Zhang X; Jaffer S; Bleiweiss IJ; Nayak A
Breast Cancer Res Treat; 2015 Oct; 153(3):565-72. PubMed ID: 26358711
[TBL] [Abstract][Full Text] [Related]
56. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
57. Should preoperative chest CT be recommended to all colon cancer patients?
Kim HY; Lee SJ; Lee G; Song L; Kim SA; Kim JY; Chang DK; Rhee PL; Kim JJ; Rhee JC; Chun HK; Kim YH
Ann Surg; 2014 Feb; 259(2):323-8. PubMed ID: 23426347
[TBL] [Abstract][Full Text] [Related]
58. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?
Ugras S; Matsen C; Eaton A; Stempel M; Morrow M; Cody HS
Ann Surg Oncol; 2016 Mar; 23(3):744-8. PubMed ID: 26644258
[TBL] [Abstract][Full Text] [Related]
59. The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy.
Spanu A; Sanna D; Chessa F; Farris A; Nuvoli S; Madeddu G
Clin Nucl Med; 2011 Nov; 36(11):997-1002. PubMed ID: 21975387
[TBL] [Abstract][Full Text] [Related]
60. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
